Safety and immunogenicity of a bivalent SARS-CoV-2 protein booster vaccine, SCTV01C in adults previously vaccinated with inactivated vaccine: A randomized, double-blind, placebo-controlled phase 1/2 clinical trial

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of infection 2023-02, Vol.86 (2), p.154-225
Hauptverfasser:	Hannawi, Suad, Saifeldin, Linda, Abuquta, Alaa, Alamadi, Ahmad, Mahmoud, Sally A., Li, Jian, Chen, Yuanxin, Xie, Liangzhi
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibodies, Neutralizing Antibodies, Viral COVID-19 - prevention & control Double-Blind Method Humans Immunogenicity, Vaccine SARS-CoV-2 Vaccines, Combined Vaccines, Inactivated - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!